TLSI
NASDAQ · Biotechnology
Trisalus Life Sciences Inc
$4.55
-0.19 (-4.01%)
Open$4.76
Previous Close$4.74
Day High$4.76
Day Low$4.49
52W High$7.95
52W Low$2.20
Volume—
Avg Volume438.0K
Market Cap268.39M
P/E Ratio—
EPS$-0.68
SectorBiotechnology
Analyst Ratings
Strong Buy
11 analysts
Price Target
-4.8% upside
Current
$4.55
$4.55
Target
$4.33
$4.33
$2.61
$4.33 avg
$5.56
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 78.37M | 47.23M | 45.65M |
| Net Income | -68,090,872 | -3,256,844 | -3,940,718 |
| Profit Margin | -86.9% | -6.9% | -8.6% |
| EBITDA | -45,685,547 | -4,196,050 | -4,663,249 |
| Free Cash Flow | — | -5,024,799 | -4,621,021 |
| Rev Growth | — | +7.1% | +0.6% |
| Debt/Equity | 0.20 | 1.07 | 0.92 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |